Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study | Zendy

KateřiezvalováHenriksen | Zendy; Olav Spigset | Zendy; Ragnhild Eek Brandlistuen | Zendy; Eivind Ystrøm | Zendy; Gideon Koren | Zendy; Hedvig Nordeng | Zendy

Open Access

Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study

Author(s) -

KateřiezvalováHenriksen,

Olav Spigset,

Ragnhild Eek Brandlistuen,

Eivind Ystrøm,

Gideon Koren,

Hedvig Nordeng

Publication year - 2016

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/dyw049

Subject(s) - medicine , pregnancy , obstetrics , gestational age , sibling , confounding , cohort study , serotonin reuptake inhibitor , depression (economics) , birth weight , cohort , prospective cohort study , gestation , population , pediatrics , antidepressant , psychiatry , psychology , anxiety , biology , developmental psychology , genetics , macroeconomics , environmental health , economics

Up to 10% of women are exposed to selective serotonin reuptake inhibitors (SSRIs) during pregnancy. Information on their effect on birthweight and gestational age remains conflicting. The aim of this sibling-controlled prospective cohort study is to address shared geneticand family-level confounding to investigate the effects of prenatal SSRI exposure and maternal depression on birthweight and gestational age.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research